Addison Advisors LLC Grows Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Addison Advisors LLC increased its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 27.4% in the fourth quarter, Holdings Channel.com reports. The fund owned 535 shares of the exchange traded fund’s stock after purchasing an additional 115 shares during the period. Addison Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $48,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in the company. Hartline Investment Corp raised its holdings in SPDR S&P Biotech ETF by 2.0% in the 3rd quarter. Hartline Investment Corp now owns 5,502 shares of the exchange traded fund’s stock worth $544,000 after acquiring an additional 106 shares during the last quarter. Signature Estate & Investment Advisors LLC raised its holdings in SPDR S&P Biotech ETF by 5.7% in the 3rd quarter. Signature Estate & Investment Advisors LLC now owns 2,336 shares of the exchange traded fund’s stock worth $231,000 after acquiring an additional 125 shares during the last quarter. Graypoint LLC raised its holdings in SPDR S&P Biotech ETF by 5.6% in the 3rd quarter. Graypoint LLC now owns 2,738 shares of the exchange traded fund’s stock worth $271,000 after acquiring an additional 146 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in SPDR S&P Biotech ETF by 0.6% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 23,873 shares of the exchange traded fund’s stock worth $2,373,000 after acquiring an additional 148 shares during the last quarter. Finally, Key Financial Inc raised its holdings in SPDR S&P Biotech ETF by 24.6% in the 3rd quarter. Key Financial Inc now owns 766 shares of the exchange traded fund’s stock worth $76,000 after acquiring an additional 151 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 1.6 %

Shares of NYSEARCA XBI opened at $88.69 on Wednesday. SPDR S&P Biotech ETF has a twelve month low of $81.14 and a twelve month high of $105.47. The firm has a market cap of $6.76 billion, a P/E ratio of 11.47 and a beta of 1.11. The company has a 50 day moving average of $91.14 and a 200 day moving average of $95.92.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.